Related content

The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis

By Karadag-Saygi Evrim   Akyuz Gulseren   Bizargity Peyman   Ay Pinar  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 1033-1036

Informa Healthcare

Access to resources Recommend Favorite

Effect of specific exercise training on bone mineral density in women with postmenopausal osteopenia or osteoporosis

By de Matos Oslei   Lopes da Silva Domingos   Martinez de Oliveira Jose   Castelo-Branco Camil  

Gynecological Endocrinology, Vol. 25, Iss. 9, 2009-09 ,pp. : 616-620

Informa Healthcare

Access to resources Recommend Favorite

Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume

By Fratzl Peter   Roschger Paul   Fratzl-Zelman Nadja   Paschalis Eleftherios   Phipps Roger   Klaushofer Klaus  

Calcified Tissue International, Vol. 81, Iss. 2, 2007-08 ,pp. : 73-80

Springer Publishing Company

Access to resources Recommend Favorite

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

By Iwamoto Jun   Takeda Tsuyoshi   Sato Yoshihiro   Uzawa Mitsuyoshi  

Clinical Rheumatology, Vol. 23, Iss. 5, 2004-10 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Risedronate on Osteocyte Viability and Bone Turnover in Paired Iliac Bone Biopsies from Early Postmenopausal Women

By Qiu S.  

Calcified Tissue International, Vol. 87, Iss. 5, 2010-11 ,pp. : 392-397

Springer Publishing Company

Access to resources Recommend Favorite